784 filings
Page 11 of 40
8-K
CRVO
CervoMed Inc
13 Aug 21
Diffusion Pharmaceuticals Reports Q2 Financial Results
4:30pm
S-8
CRVO
CervoMed Inc
12 Aug 21
Registration of securities for employees
4:50pm
10-Q
2021 Q2
CRVO
CervoMed Inc
Quarterly report
11 Aug 21
8:00am
4
CRVO
CervoMed Inc
6 Jul 21
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
9:42pm
4
Alan G Levin
6 Jul 21
Diffusion Pharmaceuticals / ALAN G LEVIN ownership change
9:42pm
4
Adams Robert W
6 Jul 21
Diffusion Pharmaceuticals / Robert W Adams ownership change
9:41pm
4
Eric Francois
6 Jul 21
Diffusion Pharmaceuticals / Eric Francois ownership change
9:41pm
4
CRVO
CervoMed Inc
6 Jul 21
Diffusion Pharmaceuticals / Mark T Giles ownership change
9:41pm
8-K
CRVO
CervoMed Inc
30 Jun 21
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
4:33pm
8-K
CRVO
CervoMed Inc
29 Jun 21
Submission of Matters to a Vote of Security Holders
9:05am
DEFA14A
CRVO
CervoMed Inc
21 Jun 21
Additional proxy soliciting materials
9:25am
DEFA14A
CRVO
CervoMed Inc
20 May 21
Additional proxy soliciting materials
4:21pm
4
CRVO
CervoMed Inc
17 May 21
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
4:27pm
8-K
CRVO
CervoMed Inc
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
10-Q
2021 Q1
CRVO
CervoMed Inc
Quarterly report
7 May 21
4:45pm
8-K
CRVO
CervoMed Inc
7 May 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
DEF 14A
CRVO
CervoMed Inc
Definitive proxy
30 Apr 21
12:00am
8-K
CRVO
CervoMed Inc
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
CRVO
CervoMed Inc
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
CRVO
CervoMed Inc
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm